<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.11 Opioid Maintenance Therapy. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.47/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.47/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|47|02|.11|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="doc-num" content=".11"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|47|02|.11" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.47.02.11"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".11 Opioid Maintenance Therapy. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.47/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.47/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|47" data-search-heading="">
                  <a href="/us/md/exec/comar/10.47" title="Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION">Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|47|02" data-search-heading="">
                  <a href="/us/md/exec/comar/10.47.02" title="Chapter 02 Specific Program Requirements">Chapter 02 Specific Program Requirements</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|47|02|.11" data-search-heading="">
                  <span title=".11 Opioid Maintenance Therapy.">.11 Opioid Maintenance Therapy.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|47|02|.11">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.47.02.11">.11 Opioid Maintenance Therapy.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> Program Description. Opioid maintenance therapy:</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> Uses pharmacological interventions, including full and partial opiate agonist treatment medications, to provide treatment, support, and recovery to opioid-addicted patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> Is a separate service that is certified and offered by a program as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.03" title=".03 Early Intervention Level 0.5.">COMAR 10.47.02.03</a> — .11;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> Complies with the requirements under this regulation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="A(4)">(4)</span> Can be provided in correctional facility based programs.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> The program shall comply with federal regulation 42 CFR 8.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> The patient to alcohol and drug counselor ratio may not exceed 50 patients to one full-time counselor.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> Medical Director. The program shall have a medical director who is a physician and who:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(a)">(a)</span> Has 3 years documented experience providing services to persons who are addicted to alcohol or other drugs, including at least 1 year of experience in the treatment of opioid addiction with opioid maintenance therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(b)">(b)</span> Meets at least one of the following criteria:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(i)">(i)</span> Has been continuously employed as the medical director for opioid maintenance therapy programs from or before August 1, 2002;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(ii)">(ii)</span> Is certified in addiction medicine by the American Society of Addiction Medicine;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(iii)">(iii)</span> Is certified in added qualifications in addiction psychiatry by the American Board of Psychiatry and Neurology, Inc.; or</p>
                <p class="text-indent-4 "><span class="level-num" id="C(2)(b)(iv)">(iv)</span> Is certified in added qualifications in addiction medicine by the appropriate specialty boards of the American Osteopathic Association; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(c)">(c)</span> Takes an active part in interdisciplinary team meetings, not less than every 2 weeks.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(3)">(3)</span> A program unable to hire a medical director who meets the criteria set forth in §C(2) of this chapter may hire an interim medical director under the following conditions:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(a)">(a)</span> The program shall submit a training plan for the interim medical director to the Administration for approval;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(b)">(b)</span> The plan shall address a means for achieving minimal competencies and proficiencies until the interim medical director meets qualifications set forth in §C(1) of this chapter; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(c)">(c)</span> The interim medical director shall meet the qualifications within 48 months of being hired.</p>
                <p class="text-indent-1 "><span class="level-num" id="D">D.</span> An opioid maintenance therapy program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="D(1)">(1)</span> Have hours that meet the needs of the patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="D(2)">(2)</span> Establish an answering system when the program is closed which provides direct contact or call back by a staff member capable of addressing emergency patient issues; and</p>
                <p class="text-indent-2 "><span class="level-num" id="D(3)">(3)</span> Complete an individualized treatment plan which is described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(a)">(a)</span> Completed and signed by the alcohol and drug counselor and patient within 7 working days of the comprehensive assessment;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(b)">(b)</span> Updated every 90 days for the first year of treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(c)">(c)</span> After completion of 1 year of continuous treatment and if the patient meets the requirements for unsupervised or take home use set forth in CFR 42 §8.12(i), the individualized treatment plan may be updated every 180 days and signed by the alcohol and drug counselor and patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="E">E.</span> Random Drug Testing. The program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="E(1)">(1)</span> Conduct random drug testing on each patient at least monthly, in accordance with State law;</p>
                <p class="text-indent-2 "><span class="level-num" id="E(2)">(2)</span> Conduct random drug testing at a minimum for the following substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="E(2)(a)">(a)</span> Benzodiazepines;</p>
                <p class="text-indent-3 "><span class="level-num" id="E(2)(b)">(b)</span> Marijuana;</p>
                <p class="text-indent-3 "><span class="level-num" id="E(2)(c)">(c)</span> Cocaine;</p>
                <p class="text-indent-3 "><span class="level-num" id="E(2)(d)">(d)</span> Opiates;</p>
                <p class="text-indent-3 "><span class="level-num" id="E(2)(e)">(e)</span> Alcohol; and</p>
                <p class="text-indent-3 "><span class="level-num" id="E(2)(f)">(f)</span> Methadone;</p>
                <p class="text-indent-2 "><span class="level-num" id="E(3)">(3)</span> Ensure that positive screens are validated using federally approved, State-certified laboratories;</p>
                <p class="text-indent-2 "><span class="level-num" id="E(4)">(4)</span> If appropriate, use temperature sensitive cups in place of direct observation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="E(5)">(5)</span> Develop procedures, approved by the Administration, that mandate clinical intervention if a patient's drug test result indicates substance use.</p>
                <p class="text-indent-1 "><span class="level-num" id="F">F.</span> Dosage. The program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="F(1)">(1)</span> Maintain patients with a dose adequate to alleviate all withdrawal symptoms;</p>
                <p class="text-indent-2 "><span class="level-num" id="F(2)">(2)</span> Employ dose increases and behavior therapy before mandatory detoxification for patients continuing to use drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="F(3)">(3)</span> Establish patient dosing on an individual need;</p>
                <p class="text-indent-2 "><span class="level-num" id="F(4)">(4)</span> Provide flexible dosage tapering at patient request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="F(5)">(5)</span> Develop a detoxification schedule at least 21 days long with daily dosage reductions less than 5 percent of the original total dose, regardless of the patient's ability to pay.</p>
                <p class="text-indent-1 "><span class="level-num" id="G">G.</span> Opioid maintenance programs shall arrange for transportation of medication to and from the following levels of care:</p>
                <p class="text-indent-2 "><span class="level-num" id="G(1)">(1)</span> Residential treatment at Levels III.3, III.5, and III.7, as described in Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.07" title=".07 Residential Services — Clinically Managed Medium Intensity Treatment Level III.3.">.07</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.09" title=".09 Residential Services — Medically Monitored Intensive Inpatient Treatment Level III.7.">.09</a> of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="G(2)">(2)</span> Detoxification services at Level III.2-D and III.7-D, as described in <a class="internal-link " href="/us/md/exec/comar/10.47.02.10" title=".10 Detoxification Services.">Regulation .10 of this chapter</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="G(3)">(3)</span> Residential treatment at Level III.1, when the patient cannot obtain or transport his or her own take-home opioid maintenance medication because of developmental or physical disabilities or because the patient does not have access to transportation.</p>
                <p class="text-indent-1 "><span class="level-num" id="H">H.</span> Opioid maintenance programs may transfer care of a patient to a closer opioid maintenance program when the patient is also being treated at a residential program or for detoxification services in a different county or jurisdiction.</p>
                <p class="text-indent-1 "><span class="level-num" id="I">I.</span> Programs may administratively detoxify or transfer a patient only if the:</p>
                <p class="text-indent-2 "><span class="level-num" id="I(1)">(1)</span> Patient's behavior on program premises is abusive, violent, or illegal;</p>
                <p class="text-indent-2 "><span class="level-num" id="I(2)">(2)</span> Patient fails to pay fees and has been informed in writing and counseled as to responsibility and possible sanctions including detoxification;</p>
                <p class="text-indent-2 "><span class="level-num" id="I(3)">(3)</span> Patient misses 3 consecutive medication days, and the program physician after a reevaluation has determined that administrative detoxification is warranted; or</p>
                <p class="text-indent-2 "><span class="level-num" id="I(4)">(4)</span> Clinical staff documents therapeutic reasons for detoxification, which may include continued use of illicit drugs or an unwillingness to follow appropriate clinical interventions.</p>
                <p class="text-indent-1 "><span class="level-num" id="J">J.</span> Criteria for Take-Home Privileges. Before the patient may take home any dose the patient shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="J(1)">(1)</span> Meet the criteria set within 42 CFR Part 8; and</p>
                <p class="text-indent-2 "><span class="level-num" id="J(2)">(2)</span> Provide the program with a working lock box for the take-home medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="K">K.</span> Referral Services. Programs shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="K(1)">(1)</span> Provide referral services as required by the level of treatment under which the program is certified; and</p>
                <p class="text-indent-2 "><span class="level-num" id="K(2)">(2)</span> Maintain a listing of agency referral agreements for the services.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.47.02.10" aria-label=".10 Detoxification Services.">
                <div class="h__ui">Previous</div>
                <span>.10 Detoxification Services.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.47.03" aria-label="Chapter 03 Specific Program Requirements for Correctional Levels of Care">
                <div class="h__ui">Next</div>
                <span>Chapter 03 Specific Program Requirements for Correctional Levels of Care</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">

<p>
      Please do not scrape. Instead, bulk download the CC-BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
